COO 170.59 Cooper Companies $COO Hit a 52 week hig
Post# of 52
Posted On: 11/19/2014 10:58:04 AM
COO 170.59 Cooper Companies $COO Hit a 52 week high of 171.14 Closing the day 09:44 at 170.59 +0.44 +0.26% With a day low of 169.76 and a total volume of 134,066.
COO Recent Posts: http://investorshangout.com/Cooper-Companies-COO-50592/
COO Cooper Companies Recent Headline News
After Yesterday's Rally of 2.34% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 17, 5:33PM CST
Cooper Cos (NYSE:COO) traded in a range yesterday that spanned from a low of $160.73 to a high of $165.51. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $164.33 on volume of 521,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COO: 169.75 (-0.40)
Cooper Cos Set to Possibly Rebound After Yesterday's Selloff of 2.78%
Comtex SmarTrend(R) - Mon Nov 10, 4:01PM CST
Cooper Cos (NYSE:COO) traded in a range yesterday that spanned from a low of $159.95 to a high of $165.86. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $163.47 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
COO: 169.75 (-0.40)
Cooper Companies (COO) Showing Signs Of Being Water-Logged And Getting Wetter
at The Street - Mon Nov 10, 2:59PM CST
Trade-Ideas LLC identified Cooper Companies (COO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
COO: 169.75 (-0.40)
The Cooper Companies Announces Release Date for Fourth Quarter and Full Year 2014
GlobeNewswire - Tue Nov 04, 3:01PM CST
The Cooper Companies, Inc. (NYSE:COO) today announced it will release fourth quarter and full year 2014 financial results on Thursday, December 4, 2014, at 4:00 PM ET. Following the release, the Company will host a conference call and live webcast with investors and analysts at 5:00 PM ET to discuss the results and current corporate developments.
COO: 169.75 (-0.40)
Cardinal Health (CAH) Beats on Q1 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:41AM CDT
Cardinal Health (CAH) reported first-quarter fiscal 2015 earnings of $1.00 per share, which beat the Zacks Consensus Estimate by 3 cents.
CAH: 80.19 (-0.82), CVS: 90.09 (-0.03), COO: 169.75 (-0.40), WAG: 67.68 (-0.38)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 80.19 (-0.82), TRNX: 26.23 (-0.29), HSIC: 132.29 (-0.10), COO: 169.75 (-0.40)
Invacare Corporation (IVC) in Focus: Stock Surges 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:18AM CDT
Invacare Corporation (IVC) was a big mover last session, as the company saw its shares nearly 15% on the day.
IVC: 15.18 (-0.51), CAH: 80.19 (-0.82), COO: 169.75 (-0.40)
CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 62.32 (-0.59), CNMD: 41.90 (-0.30), COO: 169.75 (-0.40)
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 7:50AM CDT
For 2014, CR Bard Inc. (BCR) increased its adjusted earnings per share guidance to the band of $ 8.34-$8.38 from the prior range of $8.25-$8.35.
BCR: 166.14 (-1.22), CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), COO: 169.75 (-0.40)
Patterson Companies, Quality Systems Ink Dental Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 4:38PM CDT
Through this partnership, Quality Systems Inc. (QSII) intends to leverage Patterson Companies, Inc.'s (PDCO) special market division sales force to set up a new line of business with its dental group practice customers.
ABAX: 54.29 (-0.32), PDCO: 46.54 (-0.07), QSII: 14.49 (-0.36), COO: 169.75 (-0.40)
DENTSPLY International Grows on Product Innovation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 12:10PM CDT
DENTSPLY International's (XRAY) overall growth strategy rests on product innovation.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 62.32 (-0.59), CAH: 80.19 (-0.82), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Becton, Dickinson Acquires GenCell Biosystems in Ireland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 12:10PM CDT
The GenCell acquisition will enable Becton, Dickinson and Company (BDX) to offer a differentiated platform in the NGS market, constructing a base to further expand its genomics offerings.
BDX: 130.35 (-0.59), CAH: 80.19 (-0.82), CFN: 57.75 (-0.03), COO: 169.75 (-0.40)
CR Bard's Lutonix 035: First FDA-Approved DCB in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:20PM CDT
The FDA approval for CR Bard's (BCR) Lutonix 035 DCB comes on the heels of a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel in Jun 2014.
BCR: 166.14 (-1.22), CAH: 80.19 (-0.82), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Henry Schein's BioHorizons Unveils MinerOss X Xenografts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:00PM CDT
We believe the launch of the MInerOss X family of xenografts products by BioHorizons will buoy Henry Schein's (HSIC) profitability further in the global implant market.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Cooper (COO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:22AM CDT
Cooper (COO) Enters Oversold Territory
COO: 169.75 (-0.40)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 80.19 (-0.82), LH: 101.28 (+0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 12:40PM CDT
The acquisition of EndoSee is expected to be neutral to The Cooper Companies Inc.'s (COO) fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
GlobeNewswire - Wed Oct 08, 3:01PM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system. The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
COO: 169.75 (-0.40)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 130.35 (-0.59), CAH: 80.19 (-0.82), LH: 101.28 (+0.10), COO: 169.75 (-0.40)
COO Recent Posts: http://investorshangout.com/Cooper-Companies-COO-50592/
COO Cooper Companies Recent Headline News
After Yesterday's Rally of 2.34% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 17, 5:33PM CST
Cooper Cos (NYSE:COO) traded in a range yesterday that spanned from a low of $160.73 to a high of $165.51. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $164.33 on volume of 521,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
COO: 169.75 (-0.40)
Cooper Cos Set to Possibly Rebound After Yesterday's Selloff of 2.78%
Comtex SmarTrend(R) - Mon Nov 10, 4:01PM CST
Cooper Cos (NYSE:COO) traded in a range yesterday that spanned from a low of $159.95 to a high of $165.86. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $163.47 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
COO: 169.75 (-0.40)
Cooper Companies (COO) Showing Signs Of Being Water-Logged And Getting Wetter
at The Street - Mon Nov 10, 2:59PM CST
Trade-Ideas LLC identified Cooper Companies (COO) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
COO: 169.75 (-0.40)
The Cooper Companies Announces Release Date for Fourth Quarter and Full Year 2014
GlobeNewswire - Tue Nov 04, 3:01PM CST
The Cooper Companies, Inc. (NYSE:COO) today announced it will release fourth quarter and full year 2014 financial results on Thursday, December 4, 2014, at 4:00 PM ET. Following the release, the Company will host a conference call and live webcast with investors and analysts at 5:00 PM ET to discuss the results and current corporate developments.
COO: 169.75 (-0.40)
Cardinal Health (CAH) Beats on Q1 Earnings, Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 10:41AM CDT
Cardinal Health (CAH) reported first-quarter fiscal 2015 earnings of $1.00 per share, which beat the Zacks Consensus Estimate by 3 cents.
CAH: 80.19 (-0.82), CVS: 90.09 (-0.03), COO: 169.75 (-0.40), WAG: 67.68 (-0.38)
Tornier N.V. (TRNX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 8:46AM CDT
Tornier N.V. (TRNX) was a big mover last session, with shares rising nearly 8% on the day.
CAH: 80.19 (-0.82), TRNX: 26.23 (-0.29), HSIC: 132.29 (-0.10), COO: 169.75 (-0.40)
Invacare Corporation (IVC) in Focus: Stock Surges 14.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:18AM CDT
Invacare Corporation (IVC) was a big mover last session, as the company saw its shares nearly 15% on the day.
IVC: 15.18 (-0.51), CAH: 80.19 (-0.82), COO: 169.75 (-0.40)
CONMED Q3 Earnings Rise but Revenues Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 2:10PM CDT
CONMED Corporation (CNMD) reiterated its adjusted earnings and revenue guidance for full-year 2014.
STE: 62.32 (-0.59), CNMD: 41.90 (-0.30), COO: 169.75 (-0.40)
CR Bard Beats Q3 Earnings and Revenues, '14 View Raised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 23, 7:50AM CDT
For 2014, CR Bard Inc. (BCR) increased its adjusted earnings per share guidance to the band of $ 8.34-$8.38 from the prior range of $8.25-$8.35.
BCR: 166.14 (-1.22), CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), COO: 169.75 (-0.40)
Patterson Companies, Quality Systems Ink Dental Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 4:38PM CDT
Through this partnership, Quality Systems Inc. (QSII) intends to leverage Patterson Companies, Inc.'s (PDCO) special market division sales force to set up a new line of business with its dental group practice customers.
ABAX: 54.29 (-0.32), PDCO: 46.54 (-0.07), QSII: 14.49 (-0.36), COO: 169.75 (-0.40)
DENTSPLY International Grows on Product Innovation - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 12:10PM CDT
DENTSPLY International's (XRAY) overall growth strategy rests on product innovation.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Steris (STE) to Buy UK-based Synergy Health, Save Tax - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 15, 2:30PM CDT
Following this news, Steris' (STE) share price inched up 0.3% immediately, but eventually dropped 2.5% to close at $54.99 yesterday.
STE: 62.32 (-0.59), CAH: 80.19 (-0.82), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Becton, Dickinson Acquires GenCell Biosystems in Ireland - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 14, 12:10PM CDT
The GenCell acquisition will enable Becton, Dickinson and Company (BDX) to offer a differentiated platform in the NGS market, constructing a base to further expand its genomics offerings.
BDX: 130.35 (-0.59), CAH: 80.19 (-0.82), CFN: 57.75 (-0.03), COO: 169.75 (-0.40)
CR Bard's Lutonix 035: First FDA-Approved DCB in the US - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:20PM CDT
The FDA approval for CR Bard's (BCR) Lutonix 035 DCB comes on the heels of a unanimous favorable recommendation from the FDA's Circulatory Systems Devices Advisory Panel in Jun 2014.
BCR: 166.14 (-1.22), CAH: 80.19 (-0.82), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Henry Schein's BioHorizons Unveils MinerOss X Xenografts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 2:00PM CDT
We believe the launch of the MInerOss X family of xenografts products by BioHorizons will buoy Henry Schein's (HSIC) profitability further in the global implant market.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
Cooper (COO) Enters Oversold Territory - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 7:22AM CDT
Cooper (COO) Enters Oversold Territory
COO: 169.75 (-0.40)
Cardinal Health and Ohio State Open Pharma Center - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 3:44PM CDT
The molecular imaging pharmaceuticals center will combine Ohio State's Wright Center of Innovation in Biomedical Imaging's research capabilities with Cardinal Health's (CAH) developmental, manufacturing and commercialization expertise
CAH: 80.19 (-0.82), LH: 101.28 (+0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
The Cooper Companies Acquires EndoSee for $44 Million - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 09, 12:40PM CDT
The acquisition of EndoSee is expected to be neutral to The Cooper Companies Inc.'s (COO) fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
CAH: 80.19 (-0.82), HSIC: 132.29 (-0.10), XRAY: 52.91 (-0.20), COO: 169.75 (-0.40)
The Cooper Companies' Women's Healthcare Unit Acquires EndoSee
GlobeNewswire - Wed Oct 08, 3:01PM CDT
The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical, its women's healthcare unit, has acquired EndoSee Corporation, a developer of an office-based disposable hysteroscopy system. The transaction is valued at approximately $44 million and is expected to be neutral to fiscal 2015 earnings per share excluding one-time charges and deal-related amortization.
COO: 169.75 (-0.40)
Becton, Dickinson (BDX) Jumps: Stock Moves 7.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 07, 8:46AM CDT
Becton, Dickinson (BDX) was a big mover last session, with shares rising nearly 8% on the day.
BDX: 130.35 (-0.59), CAH: 80.19 (-0.82), LH: 101.28 (+0.10), COO: 169.75 (-0.40)
(0)
(0)